CVA Family Office’s Balchem Corp BCPC Stock Holding History

CVA Family Office’s Portfolio BCPC Stock Details BCPC Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$5.74K	Buy	34 +9	+36%	+$1.5K	﹤0.01%	1226
2026 Q1	$4.24K	Buy	+25	New	+$4.25K	﹤0.01%	1286

Other funds holding BCPC

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $4.6B AUM 16.08% 1-Year Est. Return

Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.36B AUM 17.81% 1-Year Est. Return

First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return

CVA Family Office's BCPC Position: Q2 2026 in Review

CVA Family Office increased its Balchem Corp (BCPC) stake by 36% in Q2 2026, buying an estimated $1.5K and bringing the position to 34 shares worth $5.74K. The position accounts for ﹤0.01% of the portfolio, ranked #1226.

CVA Family Office first reported a position in BCPC in Q1 2026 and has held it in 2 quarters since. 417 funds tracked by Wall St. Rank hold BCPC as of Q2 2026.

CVA Family Office held 34 shares of Balchem Corp worth $5.74K as of Q2 2026.
CVA Family Office bought 9 Balchem Corp shares in Q2 2026, an estimated $1.5K.
Balchem Corp made up ﹤0.01% of CVA Family Office's portfolio in Q2 2026, its #1226 holding.
CVA Family Office first reported a position in Balchem Corp in Q1 2026 and has held it in 2 quarters since.
417 funds tracked by Wall St. Rank held Balchem Corp as of Q2 2026.

Based on CVA Family Office's 13F filing for Q2 2026, filed 7 Aug 2026.